disability

Digital mental health taking off in Europe

by

___

These 10 Euro­pean tech star­tups want to help you improve your men­tal fit­ness (Sil­i­con Canals):

“Accord­ing to a report by WHO Euro (World Health Organ­i­sa­tion Europe), in many west­ern coun­tries, men­tal health dis­or­ders are the major cause of dis­abil­i­ty, account­ing for 30% to 40% of chron­ic sick leaves, and cost­ing near­ly 3% of GDP. In addi­tion to this, [Read more…] about Dig­i­tal men­tal health tak­ing off in Europe

Trend: Rethinking (and treating) chronic pain as a brain disease

by

Can stim­u­lat­ing the brain treat chron­ic pain? (Sci­ence Daily):

“We’ve pub­lished numer­ous brain stim­u­la­tion papers over sev­er­al years, and we always learn some­thing impor­tant,” said senior author Flavio Frohlich, PhD, direc­tor of the Car­oli­na Cen­ter for Neu­rostim­u­la­tion and asso­ciate pro­fes­sor of psy­chi­a­try. “But this is the first time we’ve stud­ied chron­ic pain, and this is the only time all three ele­ments of a study lined up per­fect­ly. We suc­cess­ful­ly tar­get­ed a spe­cif­ic brain region, we enhanced or restored that region’s activ­i­ty, and we cor­re­lat­ed that enhance­ment with a sig­nif­i­cant decrease in symp­toms” Keep on reading

Neurotechnology pioneers, please design with the end-user in mind

by

John Kemp, Pres­i­dent & CEO at The Vis­car­di Cen­ter and The Hen­ry Vis­car­di School in New York

_____

The impor­tance of being seen, heard and under­stood for neu­rotech­nol­o­gy end-users (Cen­ter for Neu­rotech­nol­o­gy at Uni­ver­si­ty of Washington):

“Today, when real­is­tic-look­ing pros­thet­ic hands with artic­u­lat­ing fin­gers are becom­ing more wide­ly avail­able, one of the first things many peo­ple notice about John Kemp is that he choos­es to use pros­thet­ic met­al clamps instead of hands.

“These don’t look func­tion­al,” Kemp said, hold­ing up his clamps. “They’re high­ly func­tion­al. I wear these all day. [Read more…] about Neu­rotech­nol­o­gy pio­neers, please design with the end-user in mind

FDA clears MindMaze GO neurorehabilitation platform, easing access to continued outpatient therapy

by

___

Mind­Maze Con­sol­i­dates First-ever FDA Approval for Inpa­tient and Out­pa­tient Neu­rore­ha­bil­i­ta­tion Ther­a­py (press release):

“Mind­Maze, a leader in brain­tech, has today announced that it has obtained FDA clear­ance to launch its portable neu­rore­ha­bil­i­ta­tion prod­uct, Mind­Mo­tion™ GO, in the Unit­ed States. Togeth­er with Mind­Mo­tion PRO (which received FDA clear­ance in 2017), Mind­Mo­tion GO is the next offer­ing in the company’s con­tin­u­um of care, pro­vid­ing gam­i­fied neu­rore­ha­bil­i­ta­tion ther­a­py. [Read more…] about FDA clears Mind­Maze GO neu­rore­ha­bil­i­ta­tion plat­form, eas­ing access to con­tin­ued out­pa­tient therapy

Occupational therapy study: Improving processing speed seen as key target to help patients with multiple sclerosis

by

.

Decreased Activ­i­ty Lev­els in MS Patients Linked To Cog­ni­tive Impair­ment (Mul­ti­ple Scle­ro­sis News):

“A new study pub­lished in the Amer­i­can Jour­nal of Occu­pa­tion­al Ther­a­py assessed the cog­ni­tive fac­tors affect­ed in mul­ti­ple scle­ro­sis patients con­cern­ing their activ­i­ty and par­tic­i­pa­tion in every­day life [Read more…] about Occu­pa­tion­al ther­a­py study: Improv­ing pro­cess­ing speed seen as key tar­get to help patients with mul­ti­ple sclerosis

Invest in Brain Health to Drive Innovation and Prosperity

by

In an increas­ing­ly knowl­edge-based and inno­va­tion-dri­ven econ­o­my, human brains—not finan­cial capital—are becom­ing the pri­ma­ry dri­vers of busi­ness suc­cess. Engaged, cre­ative cit­i­zens and work­ers mean the dif­fer­ence between suc­cess and fail­ure at the orga­ni­za­tion­al and soci­etal levels.

Look­ing at the prob­lem from the per­spec­tive of brain health, there are [Read more…] about Invest in Brain Health to Dri­ve Inno­va­tion and Prosperity